ASR Vermogensbeheer’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.2M Sell
288,233
-424
-0.1% -$98.8K 0.75% 22
2026
Q1
$70.6M Buy
288,657
+5,502
+2% +$1.28M 0.83% 19
2025
Q4
$58.6M Buy
283,155
+43,032
+18% +$8.51M 0.68% 25
2025
Q3
$44.5M Sell
240,123
-746
-0.3% -$128K 0.54% 33
2025
Q2
$36.8M Buy
240,869
+12,009
+5% +$1.85M 0.48% 42
2025
Q1
$38M Buy
+228,860
New +$35.8M 0.56% 35

Other funds holding JNJ

ASR Vermogensbeheer's JNJ Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Johnson & Johnson (JNJ) stake by 0.15% in Q2 2026, selling an estimated $98.8K and leaving 288,233 shares worth $73.2M. The position accounts for 0.75% of the portfolio, ranked #22.

ASR Vermogensbeheer first reported a position in JNJ in Q1 2025 and has held it in 6 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • ASR Vermogensbeheer held 288,233 shares of Johnson & Johnson worth $73.2M as of Q2 2026.
  • ASR Vermogensbeheer sold 424 Johnson & Johnson shares in Q2 2026, an estimated $98.8K.
  • Johnson & Johnson made up 0.75% of ASR Vermogensbeheer's portfolio in Q2 2026, its #22 holding.
  • ASR Vermogensbeheer first reported a position in Johnson & Johnson in Q1 2025 and has held it in 6 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.